Year |
Citation |
Score |
2009 |
Roller S, Cui D, Laspina C, Miller-Stein C, Rowe J, Wong B, Prueksaritanont T. Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 39: 33-45. PMID 19219746 DOI: 10.1080/00498250802546861 |
0.33 |
|
2005 |
Prueksaritanont T, Qiu Y, Mu L, Michel K, Brunner J, Richards KM, Lin JH. Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: Effects of gemfibrozil Pharmaceutical Research. 22: 1101-1109. PMID 16028010 DOI: 10.1007/s11095-005-6037-2 |
0.305 |
|
2002 |
Prueksaritanont T, Zhao JJ, Ma B, Roadcap BA, Tang C, Qiu Y, Liu L, Lin JH, Pearson PG, Baillie TA. Mechanistic studies on metabolic interactions between gemfibrozil and statins. The Journal of Pharmacology and Experimental Therapeutics. 301: 1042-51. PMID 12023536 DOI: 10.1124/jpet.301.3.1042 |
0.3 |
|
2002 |
Prueksaritanont T, Subramanian R, Fang X, Ma B, Qiu Y, Lin JH, Pearson PG, Baillie TA. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 505-12. PMID 11950779 DOI: 10.1124/dmd.30.5.505 |
0.34 |
|
1996 |
d'Uscio CH, Aweeka FT, Prueksaritanont T, Tomlanovich SJ, Gupta SK, Lantz MV, Gambertoglio JG, Garovoy MR, Benet LZ. Immunopharmacodynamic studies of cyclosporine in patients awaiting renal transplantation. Journal of Clinical Pharmacology. 35: 967-73. PMID 8568014 DOI: 10.1002/J.1552-4604.1995.Tb04012.X |
0.304 |
|
1989 |
Prueksaritanont T, Sittichai N, Prueksaritanont S, Vongsaroj R. Simultaneous determination of ranitidine and its metabolites in human plasma and urine by high-performance liquid chromatography Journal of Chromatography B: Biomedical Sciences and Applications. 490: 175-185. PMID 2760148 DOI: 10.1016/S0378-4347(00)82772-3 |
0.379 |
|
1988 |
Hsu FH, Prueksaritanont T, Lee MG, Chiou WL. The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: extrapolation to human data based on the body surface area concept. Journal of Pharmacokinetics and Biopharmaceutics. 15: 369-86. PMID 3681665 DOI: 10.1007/Bf01066519 |
0.557 |
|
1987 |
Prueksaritanont T, Chiou WL. Absorption of iothalamate after oral administration: a preliminary study in humans and interspecies differences. Biopharmaceutics & Drug Disposition. 8: 99-101. PMID 3580517 DOI: 10.1002/Bdd.2510080111 |
0.531 |
|
1987 |
Prueksaritanont T, Lee MG, Hsu FH, Chiou WL. Absorption of iothalamate after oral administration and absorption enhancement by amino acids in dogs and rats. Biopharmaceutics & Drug Disposition. 7: 463-78. PMID 2430637 DOI: 10.1002/Bdd.2510070507 |
0.549 |
|
1986 |
Prueksaritanont T, Lui CY, Lee MG, Chiou WL. Renal and non-renal clearances of iothalamate. Biopharmaceutics & Drug Disposition. 7: 347-55. PMID 3768490 DOI: 10.1002/Bdd.2510070405 |
0.493 |
|
1984 |
Prueksaritanont T, Chen ML, Chiou WL. Simple and micro high-performance liquid chromatographic method for simultaneous determination of p-aminohippuric acid and iothalamate in biological fluids. Journal of Chromatography. 306: 89-97. PMID 6609166 DOI: 10.1016/S0378-4347(00)80872-5 |
0.505 |
|
Show low-probability matches. |